SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-010449
Filing Date
2018-08-08
Accepted
2018-08-08 16:03:58
Documents
51
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0618_soligenixinc.htm 10-Q 459897
2 CERTIFICATION f10q0618ex31-1_soligenixinc.htm EX-31.1 10154
3 CERTIFICATION f10q0618ex31-2_soligenixinc.htm EX-31.2 10105
4 CERTIFICATION f10q0618ex32-1_soligenixinc.htm EX-32.1 3655
5 CERTIFICATION f10q0618ex32-2_soligenixinc.htm EX-32.2 3702
  Complete submission text file 0001213900-18-010449.txt   2868248

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20180630.xml EX-101.INS 522050
7 XBRL SCHEMA FILE sngx-20180630.xsd EX-101.SCH 33339
8 XBRL CALCULATION FILE sngx-20180630_cal.xml EX-101.CAL 31972
9 XBRL LABEL FILE sngx-20180630_lab.xml EX-101.LAB 309964
10 XBRL DEFINITION FILE sngx-20180630_def.xml EX-101.DEF 101776
11 XBRL PRESENTATION FILE sngx-20180630_pre.xml EX-101.PRE 187385
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 181001315
SIC: 2834 Pharmaceutical Preparations